Bandim Health Project

This study in Guinea-Bissau tests whether the BCG vaccine (normally used for tuberculosis) can prevent or delay type 2 diabetes in 200 adults with pre-diabetes. Researchers believe the vaccine may reduce inflammation and insulin resistance. The goal is to find a low-cost way to c…

This study in Guinea-Bissau tests whether making the BCG vaccine available every day (instead of only certain days) can reduce early infant deaths. About 22,800 newborns will be followed for 42 days after birth. The goal is to see if earlier vaccination lowers deaths from causes …